Logo image of AYJ.DE

VALNEVA SE (AYJ.DE) Stock Price, Quote, News and Overview

FRA:AYJ - Deutsche Boerse Ag - FR0004056851 - Common Stock - Currency: EUR

3.764  +0.17 (+4.79%)

AYJ.DE Quote, Performance and Key Statistics

VALNEVA SE

FRA:AYJ (8/8/2025, 7:00:00 PM)

3.764

+0.17 (+4.79%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High4.2
52 Week Low1.73
Market Cap320.06M
Shares85.03M
Float75.00M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-12 2025-08-12/bmo
IPO06-28 2007-06-28


AYJ.DE short term performance overview.The bars show the price performance of AYJ.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30 40

AYJ.DE long term performance overview.The bars show the price performance of AYJ.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 -40

The current stock price of AYJ.DE is 3.764 EUR. In the past month the price increased by 49.6%. In the past year, price increased by 20.49%.

VALNEVA SE / AYJ Daily stock chart

AYJ.DE Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
4AB.DE ABBVIE INC 18.64 299.58B
AMG.DE AMGEN INC 13.77 132.01B
GIS.DE GILEAD SCIENCES INC 15.46 127.88B
VX1.DE VERTEX PHARMACEUTICALS INC N/A 81.12B
1REGN.MI REGENERON PHARMACEUTICALS 12.43 52.62B
ARGX.BR ARGENX SE 76.6 34.79B
22UA.DE BIONTECH SE-ADR N/A 23.13B
1BIIB.MI BIOGEN INC 8.37 16.66B
IDP.DE BIOGEN INC 7.99 16.10B
1MRNA.MI MODERNA INC N/A 8.76B
0QF.DE MODERNA INC N/A 8.73B
ABVX.PA ABIVAX SA N/A 4.54B

About AYJ.DE

Company Profile

AYJ logo image Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. The company is headquartered in Saint-Herblain, Pays De La Loire and currently employs 695 full-time employees. The company went IPO on 2007-06-28. The firm's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The firm has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The firm is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.

Company Info

VALNEVA SE

6 rue Alain Bombard

Saint-Herblain PAYS DE LA LOIRE FR

Employees: 695

AYJ Company Website

AYJ Investor Relations

Phone: 33228073710

VALNEVA SE / AYJ.DE FAQ

What is the stock price of VALNEVA SE today?

The current stock price of AYJ.DE is 3.764 EUR. The price increased by 4.79% in the last trading session.


What is the ticker symbol for VALNEVA SE stock?

The exchange symbol of VALNEVA SE is AYJ and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is AYJ.DE stock listed?

AYJ.DE stock is listed on the Deutsche Boerse Ag exchange.


What is the price forecast or stock price prediction for VALNEVA SE stock?

12 analysts have analysed AYJ.DE and the average price target is 7.6 EUR. This implies a price increase of 101.85% is expected in the next year compared to the current price of 3.764. Check the VALNEVA SE stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is VALNEVA SE worth?

VALNEVA SE (AYJ.DE) has a market capitalization of 320.06M EUR. This makes AYJ.DE a Small Cap stock.


How many employees does VALNEVA SE have?

VALNEVA SE (AYJ.DE) currently has 695 employees.


What are the support and resistance levels for VALNEVA SE (AYJ.DE) stock?

VALNEVA SE (AYJ.DE) has a support level at 3.44 and a resistance level at 3.77. Check the full technical report for a detailed analysis of AYJ.DE support and resistance levels.


Is VALNEVA SE (AYJ.DE) expected to grow?

The Revenue of VALNEVA SE (AYJ.DE) is expected to grow by 6.79% in the next year. Check the estimates tab for more information on the AYJ.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy VALNEVA SE (AYJ.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does VALNEVA SE (AYJ.DE) stock pay dividends?

AYJ.DE does not pay a dividend.


When does VALNEVA SE (AYJ.DE) report earnings?

VALNEVA SE (AYJ.DE) will report earnings on 2025-08-12, before the market open.


What is the Price/Earnings (PE) ratio of VALNEVA SE (AYJ.DE)?

VALNEVA SE (AYJ.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.54).


AYJ.DE Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to AYJ.DE. When comparing the yearly performance of all stocks, AYJ.DE is one of the better performing stocks in the market, outperforming 87.9% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

AYJ.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to AYJ.DE. AYJ.DE may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AYJ.DE Financial Highlights

Over the last trailing twelve months AYJ.DE reported a non-GAAP Earnings per Share(EPS) of -0.54. The EPS decreased by -184.21% compared to the year before.


Industry RankSector Rank
PM (TTM) 15.08%
ROA 7.48%
ROE 20.65%
Debt/Equity 1.06
Chartmill High Growth Momentum
EPS Q2Q%-114.63%
Sales Q2Q%50.31%
EPS 1Y (TTM)-184.21%
Revenue 1Y (TTM)17.86%

AYJ.DE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to AYJ.DE. The Buy consensus is the average rating of analysts ratings from 12 analysts.

For the next year, analysts expect an EPS growth of -597.38% and a revenue growth 6.79% for AYJ.DE


Ownership
Inst Owners23.31%
Ins Owners0.22%
Short Float %N/A
Short RatioN/A
Analysts
Analysts83.33
Price Target7.6 (101.91%)
EPS Next Y-597.38%
Revenue Next Year6.79%